PERBEDAAN KADAR HEMOGLOBIN SEBELUM DAN SESUDAH KEMOTERAPI PADA PASIEN KARSINOMA MAMMAE YANG DIRAWAT DI RUMAH SAKIT MOHAMMAD HOESIN

WHEI, SEE JIA and Susilawati, Susilawati and Suciati, Tri (2019) PERBEDAAN KADAR HEMOGLOBIN SEBELUM DAN SESUDAH KEMOTERAPI PADA PASIEN KARSINOMA MAMMAE YANG DIRAWAT DI RUMAH SAKIT MOHAMMAD HOESIN. Undergraduate thesis, Sriwijaya University.

[thumbnail of RAMA_11201_04011381621229.pdf] Text
RAMA_11201_04011381621229.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (2MB) | Request a copy
[thumbnail of RAMA_11201_04011381621229_TURNITIN.pdf] Text
RAMA_11201_04011381621229_TURNITIN.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (7MB) | Request a copy
[thumbnail of RAMA_11201_04011381621229_0027027806_0014078306_01_front_ref.pdf]
Preview
Text
RAMA_11201_04011381621229_0027027806_0014078306_01_front_ref.pdf - Accepted Version
Available under License Creative Commons Public Domain Dedication.

Download (1MB) | Preview
[thumbnail of RAMA_11201_04011381621229_0027027806_0014078306_02.pdf] Text
RAMA_11201_04011381621229_0027027806_0014078306_02.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (828kB) | Request a copy
[thumbnail of RAMA_11201_04011381621229_0027027806_0014078306_03.pdf] Text
RAMA_11201_04011381621229_0027027806_0014078306_03.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (457kB) | Request a copy
[thumbnail of RAMA_11201_04011381621229_0027027806_0014078306_04.pdf] Text
RAMA_11201_04011381621229_0027027806_0014078306_04.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (332kB) | Request a copy
[thumbnail of RAMA_11201_04011381621229_0027027806_0014078306_05.pdf] Text
RAMA_11201_04011381621229_0027027806_0014078306_05.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (8kB) | Request a copy
[thumbnail of RAMA_11201_04011381621229_0027027806_0014078306_06_ref.pdf] Text
RAMA_11201_04011381621229_0027027806_0014078306_06_ref.pdf - Bibliography
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (420kB) | Request a copy
[thumbnail of RAMA_11201_04011381621229_0027027806_0014078306_07_lamp.pdf] Text
RAMA_11201_04011381621229_0027027806_0014078306_07_lamp.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (1MB) | Request a copy

Abstract

Backgrounds: Mammary carcinoma is a malignant tumor that occurs in breast cells. Anemia is the most common complication in mammary carcinoma patients that can be caused by chemical factors produced by mammary carcinoma or chemotherapy treatment factors. Chemotherapy can cause anemia by damaging the process of hematopoiesis which is accompanied by a decrease in hemoglobin because of the reduced amount of erythrocytes. This study aims to determine the differences in hemoglobin levels before and after chemotherapy in mammary carcinoma patients treated at Mohammad Hoesin Hospital in Palembang. Method: This study approaches using the observational analytic cross-sectional design. Sampling was done by using the consecutive sampling technique with a total of 50 respondent mammary carcinoma patients undergoing chemotherapy at RSUP Dr. Mohammad Hoesin Palembang in September 2019. Results: In this study it was found that the age group that suffered the most from mammary carcinoma was the age group 41-50 years with 51-60 years as many as 13 people (26%). The mean and standard deviation of hemoglobin levels before chemotherapy in 50 mammary carcinoma patients, 12.082 ± 1.5157, was higher than the hemoglobin levels after chemotherapy in 50 patients, 10.676 ± 1.5564. In this study, the p value is 0.000 <0.05, meaning that with a confidence level of 95% it can be stated that there are differences in hemoglobin levels before and after chemotherapy in mammary carcinoma patients. Conclusion: There are differences in hemoglobin levels before and after chemotherapy in mammary carcinoma patients.

Item Type: Thesis (Undergraduate)
Uncontrolled Keywords: kadar hemoglobin, kemoterapi, karsinoma mammae
Subjects: R Medicine > R Medicine (General) > R735-854 Medical education. Medical schools. Research
Divisions: 04-Faculty of Medicine > 11201-Medicine (S1)
Depositing User: Users 4116 not found.
Date Deposited: 10 Jan 2020 05:20
Last Modified: 10 Jan 2020 05:20
URI: http://repository.unsri.ac.id/id/eprint/23685

Actions (login required)

View Item View Item